Search Results

Arzoxifene: the evidence for its development in the management of breast cancer

Authors: Jackson, Lee R.; Cheung, Kwok L.; Buzdar, Aman U.; Robertson, John F.R.

Source: Core Evidence, Volume 2, Number 4, July 2008 , pp. 251-258(8)

Publisher: Core Medical Publishing

Estrogen Receptor Modulators and Down Regulators: Optimal Use in Postmenopausal Women With Breast Cancer

Authors: Baumann, Christa K.; Castiglione-Gertsch, Monica

Source: Drugs, Volume 67, Number 16, 2007 , pp. 2335-2353(19)

Publisher: Adis International

Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: Current State of Development

Authors: Gennari, Luigi; Merlotti, Daniela; Valleggi, Fabrizio; Martini, Giuseppe; Nuti, Ranuccio

Source: Drugs & Aging, Volume 24, Number 5, 2007 , pp. 361-379(19)

Publisher: Adis International

Developments in the pharmacotherapeutic management of osteoporosis

Authors: Close, Pierre; Neuprez, Audrey; Reginster, Jean-Yves

Source: Expert Opinion on Pharmacotherapy, Volume 7, Number 12, August 2006 , pp. 1603-1615(13)

Publisher: Informa Healthcare

Arzoxifene: the development and clinical outcome of an ideal SERM

Author: Munster, Pamela N

Source: Expert Opinion on Investigational Drugs, Volume 15, Number 3, 1 March 2006 , pp. 317-326(10)

Publisher: Informa Healthcare

Estrogen Receptors as Therapeutic Targets in Breast Cancer

Authors: Ariazi, Eric A.; Ariazi, Jennifer L.; Cordera, Fernando; Jordan, V. C.

Source: Current Topics in Medicinal Chemistry, Volume 6, Number 3, February 2006 , pp. 181-202(22)

Publisher: Bentham Science Publishers

Emerging Selective Estrogen Receptor Modulators: Special Focus on Effects on Coronary Heart Disease in Postmenopausal Women

Authors: Vogelvang, Tatjana Elène; Marius Jan van der Mooren,; Mijatovic, Velja; Kenemans, Peter

Source: Drugs, Volume 66, Number 2, 2006 , pp. 191-221(31)

Publisher: Adis International

Urogenital effects of selective estrogen receptor modulators: a systematic review

Authors: Albertazzi, P.; Sharma, S.

Source: Climacteric, Volume 8, Number 3, September 2005 , pp. 214-220(7)

Publisher: Informa Healthcare

Arzoxifene for prevention of breast cancer: still "excellent candidate"

Source: Inpharma, Volume 1, Number 1457, 2004-10-02 , pp. 8-8(1)

Publisher: Adis International

Novel therapies for osteoporosis

Author: Biskobing D.M.

Source: Expert Opinion on Investigational Drugs, Volume 12, Number 4, 1 April 2003 , pp. 611-621(11)

Publisher: Informa Healthcare

Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients

Authors: J. Baselga; A. Llombart-Cussac; M. Bellet; V. Guillem-Porta; N. Enas; K. Krejcy; E. Carrasco; L. Kayitalire; M. Kuta; A. Lluch; P. Vodvarka; P. Kerbrat; M. Namer; L. Petruzelka

Source: Annals of Oncology, Volume 14, Number 9, September 2003 , pp. 1383-1390(8)

Publisher: Oxford University Press

Laboratory variables to stratify metastatic colorectal cancer patients

Author: J. Watine

Source: Annals of Oncology, Volume 14, Number 9, September 2003 , pp. 1450-1451(2)

Publisher: Oxford University Press

R.R. Barakat, M.W. Bevers, D.M. Gershenson and W.J. Hoskins (eds). Handbook of Gynecologic Oncology, second edition

Author: G. Egli

Source: Annals of Oncology, Volume 14, Number 9, September 2003 , pp. 1453-1453(1)

Publisher: Oxford University Press

A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer

Authors: McMeekin D.S.; Gordon A.; Fowler J.; Melemed A.; Buller R.; Burke T.; Bloss J.; Sabbatini P.

Source: Gynecologic Oncology, Volume 90, Number 1, July 2003 , pp. 64-69(6)

Publisher: Elsevier

Pharmacokinetics of Selective Estrogen Receptor Modulators

Authors: Morello K.C.; Wurz G.T.; DeGregorio M.W.

Source: Clinical Pharmacokinetics, Volume 42, Number 4, 2003 , pp. 361-372(12)

Publisher: Adis International

Arzoxifene in breast cancer

Author: Chan S.

Source: European Journal of Cancer, Volume 38, Supplement 6, September 2002 , pp. 55-56(2)

Publisher: Elsevier

Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?

Authors: Howell A.; Howell S.J.; Clarke R.; Anderson E.

Source: The Journal of Steroid Biochemistry and Molecular Biology, Volume 79, Number 1, December 2001 , pp. 227-237(11)

Publisher: Elsevier

Non Steroidal Estrogen Antagonists: Current Status and Future Perspectives

Authors: Hajela K.; Jha A.K.; Pandey J.

Source: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Volume 1, Number 3, November 2001 , pp. 235-256(27)

Publisher: Bentham Science Publishers

Arzoxifene `potentially active' in advanced breast cancer

Source: Inpharma, Volume 1, Number 1287, 2001 , pp. 9-9(1)

Publisher: Adis International